Hormonal
Higher habitual and lunch-specific carbohydrate quality index (CQI) is significantly associated with a reduced odds of low HDL cholesterol, but shows no significant association with metabolic syndrome or other MetS components.
Focus on the quality of carbohydrates you eat, particularly at lunch and throughout your habitual diet, to support healthy HDL cholesterol levels. This involves choosing foods with higher fiber, lower glycemic index, and fewer solid sugars. However, do not assume that high carbohydrate quality alone will prevent metabolic syndrome; you must also manage other factors like blood pressure, blood sugar, and waist circumference through comprehensive lifestyle changes.
In habitual meal, before and after adjustment for the covariate, the odds ratio of low-HDL in third tertiles of CQI was significantly lower than the first tertiles [odds ratio (OR): 0.67; 95% CI: 0.47–0.96]. Moreover, within lunch meals, CQI is associated with low-HDL (OR: 0.66; 95% CI: 0.47–0.94) before and after adjustment for potential cofounding.
Why this rating
Cross-sectional design limits causal inference; however, the sample size (n=850) is robust and adjustments for covariates are extensive.
Source
Habitual- and Meal-Specific Carbohydrate Quality Index and Their Relation to Metabolic Syndrome in a Sample of Iranian Adults
Maryam Majdi et al. · Frontiers in Nutrition · 2022
DOI 10.3389/fnut.2022.763345
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →